ClinicalTrialsFinder
RecruitingNCT07231159

Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots

Sponsor

AdventHealth

Enrollment

200 participants

Start Date

Nov 17, 2025

Study Type

OBSERVATIONAL

Conditions

Breast CancerProstate CancerLung Cancer (Diagnosis)

Summary

To evaluate a community-based outreach initiative for screening, diagnosis, and treatment of breast, lung, and prostate cancers in underserved adults using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) implementation science framework.

Eligibility

Min Age: 18 Years

Inclusion Criteria7

  • Adult aged 18 or older
  • Seeking care at a CRS or emergency department
  • Meets criteria for lung, breast, and/or prostate cancer screening, as outlined below:
  • Lung cancer: Adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years
  • Breast cancer: Women aged 40 to 74 years
  • Prostate cancer: Men aged 55 to 69 years
  • Receives a positive screening result for lung, breast, and/or prostate cancer at a study site

Exclusion Criteria2

  • Displays behavior disruptive to other patients or staff
  • Refusal to accept screening for breast, lung, and/or prostate cancers

Interventions

BEHAVIORALreferral for definitive diagnosis based on their cancer screening results

Need for radiological diagnosis

BEHAVIORALEngagement

Engage in stakeholder focus groups to provide feedback about program operations

Locations(1)

Adventhealth

Orlando, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07231159

Related Trials

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

NCT0661828763 locations

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

NCT071689933 locations

Early Phase Study of KESONOTIDE™in Participants With Solid Tumours

NCT069260753 locations

Cardiac Outcomes With Near-Complete Estrogen Deprivation

NCT053096553 locations

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

NCT041190243 locations